TP53 and head and neck squamous cell carcinoma: Upcoming studies should integrate genetic data, such as TP53 (13) mutations and P16 overexpression (28), with radiomics to more comprehensively characterize head and neck squamous cell carcinoma and offer a non-invasive, multimodal approach to OSCC outcome prediction.